Biogen to acquire Apellis for $5.6 billion in cash deal

March 31, 2026 6:59 AM

Biogen Inc. (NASDAQ: BIIB) announced it will acquire Apellis Pharmaceuticals Inc. (NASDAQ: APLS) for $41 per share in cash, representing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found